These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 34121090)

  • 1. Cascade screening for beta-thalassemia in Pakistan: development, feasibility and acceptability of a decision support intervention for relatives.
    Ahmed S; Jafri H; Rashid Y; Ehsan Y; Bashir S; Ahmed M
    Eur J Hum Genet; 2022 Jan; 30(1):73-80. PubMed ID: 34121090
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cascade screening for beta-thalassaemia in Pakistan: relatives' experiences of a decision support intervention in routine practice.
    Ahmed S; Jafri H; Faran M; Ahmed WN; Rashid Y; Ehsan Y; Ahmed M
    Eur J Hum Genet; 2022 Apr; 30(4):406-412. PubMed ID: 34608271
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Healthcare professionals' perceptions of implementing a decision support intervention for cascade screening for beta-thalassemia in Pakistan.
    Ahmed S; Jafri H; Ahmed WN; Faran M; Rashid Y; Ehsan Y; Ahmed M
    Eur J Hum Genet; 2022 Jul; 30(7):795-799. PubMed ID: 35228680
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevention of beta-thalassemia in a large Pakistani family through cascade testing.
    Baig SM; Din MA; Hassan H; Azhar A; Baig JM; Aslam M; Anjum I; Farooq M; Hussain MS; Rasool M; Nawaz S; Qureshi JA; Zaman T
    Community Genet; 2008; 11(1):68-70. PubMed ID: 18196920
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Frequency of carrier screening and preventive orientation among first degree relatives of Thalassaemia patients.
    Hashim S; Sarwar M; Arsalan A; Awan I; Naseem S
    J Pak Med Assoc; 2018 Jan; 68(1):50-54. PubMed ID: 29371718
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Carrier screening for beta-thalassaemia: a review of international practice.
    Cousens NE; Gaff CL; Metcalfe SA; Delatycki MB
    Eur J Hum Genet; 2010 Oct; 18(10):1077-83. PubMed ID: 20571509
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Joint SOGC-CCMG Opinion for Reproductive Genetic Carrier Screening: An Update for All Canadian Providers of Maternity and Reproductive Healthcare in the Era of Direct-to-Consumer Testing.
    Wilson RD; De Bie I; Armour CM; Brown RN; Campagnolo C; Carroll JC; Okun N; Nelson T; Zwingerman R; Audibert F; Brock JA; Brown RN; Campagnolo C; Carroll JC; De Bie I; Johnson JA; Okun N; Pastruck M; Vallée-Pouliot K; Wilson RD; Zwingerman R; Armour C; Chitayat D; De Bie I; Fernandez S; Kim R; Lavoie J; Leonard N; Nelson T; Taylor S; Van Allen M; Van Karnebeek C
    J Obstet Gynaecol Can; 2016 Aug; 38(8):742-762.e3. PubMed ID: 27638987
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autonomous decision-making for antenatal screening in Pakistan: views held by women, men and health professionals in a low-middle income country.
    Ahmed S; Jafri H; Rashid Y; Yi H; Dong D; Zhu J; Ahmed M
    Eur J Hum Genet; 2019 Jun; 27(6):848-856. PubMed ID: 30718884
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevention programmes and prenatal diagnosis for beta thalassemia in Pakistan: A narrative review.
    Ghafoor M; Sabar MF; Sabir F
    J Pak Med Assoc; 2021 Jan; 71(1(B)):326-331. PubMed ID: 35157672
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A qualitative systematic review of internal and external influences on shared decision-making in all health care settings.
    Truglio-Londrigan M; Slyer JT; Singleton JK; Worral P
    JBI Libr Syst Rev; 2012; 10(58):4633-4646. PubMed ID: 27820528
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prenatal diagnosis of beta-thalassemia in Southern Punjab, Pakistan.
    Baig SM; Azhar A; Hassan H; Baig JM; Aslam M; Ud Din MA; Qureshi JA; Zaman T
    Prenat Diagn; 2006 Oct; 26(10):903-5. PubMed ID: 16821247
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The influence of social and cultural practices on maternal mortality: a qualitative study from South Punjab, Pakistan.
    Omer S; Zakar R; Zakar MZ; Fischer F
    Reprod Health; 2021 May; 18(1):97. PubMed ID: 34006307
    [TBL] [Abstract][Full Text] [Related]  

  • 13. How to inform relatives at risk of hereditary diseases? A mixed-methods systematic review on patient attitudes.
    van den Heuvel LM; Smets EMA; van Tintelen JP; Christiaans I
    J Genet Couns; 2019 Oct; 28(5):1042-1058. PubMed ID: 31216099
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interpretations of autonomous decision-making in antenatal genetic screening among women in China, Hong Kong and Pakistan.
    Ahmed S; Yi H; Dong D; Zhu J; Jafri H; Rashid Y; Ngan OM; Ahmed M
    Eur J Hum Genet; 2018 Apr; 26(4):495-504. PubMed ID: 29386663
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Attitudes of relatives of mucopolysaccharidosis type III patients toward preconception expanded carrier screening.
    Nijmeijer SCM; Conijn T; Lakeman P; Henneman L; Wijburg FA; Haverman L
    Eur J Hum Genet; 2020 Oct; 28(10):1331-1340. PubMed ID: 32483342
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The AMBER care bundle for hospital inpatients with uncertain recovery nearing the end of life: the ImproveCare feasibility cluster RCT.
    Koffman J; Yorganci E; Murtagh F; Yi D; Gao W; Barclay S; Pickles A; Higginson I; Johnson H; Wilson R; Bailey S; Ewart C; Evans C
    Health Technol Assess; 2019 Oct; 23(55):1-150. PubMed ID: 31594555
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development and field testing of a tool to elicit women's preferences among cervical cancer screening modalities.
    Wood B; Taljaard M; El-Khatib Z; McFaul S; Graham ID; Little J
    J Eval Clin Pract; 2019 Dec; 25(6):1169-1181. PubMed ID: 31423705
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cancer Predisposition Cascade Screening for Hereditary Breast/Ovarian Cancer and Lynch Syndromes in Switzerland: Study Protocol.
    Katapodi MC; Viassolo V; Caiata-Zufferey M; Nikolaidis C; Bührer-Landolt R; Buerki N; Graffeo R; Horváth HC; Kurzeder C; Rabaglio M; Scharfe M; Urech C; Erlanger TE; Probst-Hensch N; Heinimann K; Heinzelmann-Schwarz V; Pagani O; Chappuis PO
    JMIR Res Protoc; 2017 Sep; 6(9):e184. PubMed ID: 28931501
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Beta-thalassaemia carrier detection by ELISA: a simple screening strategy for developing countries.
    Ravindran MS; Patel ZM; Khatkhatay MI; Dandekar SP
    J Clin Lab Anal; 2005; 19(1):22-5. PubMed ID: 15645468
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.